Matthias Noack-Rink   Noack-Rink

2023-11 - heute
Independent Consultant Epilepsy/CNS
Independent Consultant / Interims Management

2020-07 - 2023-10
Medical Affairs Director
Angelini Pharma Deutschland GmbH

2020-01 - 2020-07
Field Medical Lead Germany
Arvelle Therapeutics

2018-01 - 2019-12
Independent Consultant (Epilepsy and related topics)
self employed

2015-03 - 2017-12
Global Lead Expanding Better Epilepsy Care
UCB Pharma

2013-04 - 2015-02
Medical Lead Global Keppra Patient Solutions Team
UCB Pharma

2008-11 - 2013-03
Medical Head of Therapeutic Area Epilepsy
UCB Pharma GmbH

2007-09 - 2008-10
Head of MSLs CNS
UCB Pharma GmbH

2004-01 - 2007-08
Senior Medical Science Liaison (MSL)
UCB Pharma GmbH

2001-04 - 2003-12
Co-owner and Managing Director
MCR Institute

2000-05 - 2001-03
Senior Consultant
helix health media marketing GmbH

1996-04 - 2000-04
Product Manager CNS
Janssen-Cilag GmbH, Neuss

1989-06 - 1996-03
Product Manager Animal Health
Janssen-Cilag GmbH, Neuss

1987-04 - 1989-05
Sales Representative Hospital
Boehringer Mannheim GmbH

Veterinary medicine

Deutsch Muttersprache, Englisch Fließend